Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Achard V, Putora P, Zwahlen D, Couñago F, Scorsetti M, Eito C, Barrado M, Zapatero A, Muto P, Van De Voorde L, Lamanna G, Koutsouvelis N, Dipasquale G, Ost P, Meersschout S, Guckenberger M, Jaccard M, Vanhoutte F, Siva S, Heikkilä R, Dirix P, Liefhooghe N, Otte F, Gomez-Iturriaga A, Berghen C, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Zilli T. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiother Oncol 2022; 172:1-9.
26.04.2022
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
26.04.2022
Radiother Oncol 2022; 172:1-9
Achard Vérane, Putora Paul Martin, Zwahlen Daniel, Couñago Felipe, Scorsetti Marta, Eito Clara, Barrado Marta, Zapatero Almudena, Muto Paolo, Van De Voorde Lien, Lamanna Giorgio, Koutsouvelis Nikolaos, Dipasquale Giovanna, Ost Piet, Meersschout Sabine, Guckenberger Matthias, Jaccard Maud, Vanhoutte Frederik, Siva Shankar, Heikkilä Reino, Dirix Piet, Liefhooghe Nick, Otte François-Xavier, Gomez-Iturriaga Alfonso, Berghen Charlien, Shelan Mohamed, Conde-Moreno Antonio, López Campos Fernando, Papachristofilou Alexandros, Zilli Thomas
Weiter
